Gastrointestinal Disorders in Cystic Fibrosis
- PMID: 26857772
- DOI: 10.1016/j.ccm.2015.11.004
Gastrointestinal Disorders in Cystic Fibrosis
Abstract
Gastrointestinal (GI) manifestations commonly complicate the care of patients with cystic fibrosis (CF). Despite recent approval of CF transmembrane conductance regulator modulating agents that can improve pulmonary function, GI disorders continue to be relevant and require innovative therapies. This article discusses the most common GI complications of CF, including reflux, pancreatic insufficiency, small bowel intestinal overgrowth, distal intestinal obstruction syndrome, and GI malignancy, with emphasis on clinical presentation and management.
Keywords: Constipation; Cystic fibrosis; Distal intestinal obstruction syndrome; Dysmotility; Gastrointestinal malignancy; Pancreas insufficiency; Pancreatitis; Reflux.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis.Rev Mal Respir. 2015 Jun;32(6):566-85. doi: 10.1016/j.rmr.2014.12.008. Epub 2015 May 19. Rev Mal Respir. 2015. PMID: 26001957 Review.
-
Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis.Curr Gastroenterol Rep. 2024 Jan;26(1):9-19. doi: 10.1007/s11894-023-00906-4. Epub 2023 Dec 7. Curr Gastroenterol Rep. 2024. PMID: 38057499 Review.
-
Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy.Nutr Clin Pract. 2024 Apr;39 Suppl 1:S57-S77. doi: 10.1002/ncp.11122. Nutr Clin Pract. 2024. PMID: 38429959 Review.
-
Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.Paediatr Respir Rev. 2022 Jun;42:9-16. doi: 10.1016/j.prrv.2020.12.001. Epub 2020 Dec 24. Paediatr Respir Rev. 2022. PMID: 33485777 Review.
-
Beyond pancreatic insufficiency and liver disease in cystic fibrosis.Eur J Pediatr. 2016 Jul;175(7):881-94. doi: 10.1007/s00431-016-2719-5. Epub 2016 Apr 7. Eur J Pediatr. 2016. PMID: 27055450 Review.
Cited by
-
The current state of gastrointestinal motility evaluation in cystic fibrosis: a comprehensive literature review.Transl Gastroenterol Hepatol. 2023 Dec 6;9:10. doi: 10.21037/tgh-23-59. eCollection 2024. Transl Gastroenterol Hepatol. 2023. PMID: 38317748 Free PMC article. Review.
-
Pro-inflammatory cytokines stimulate CFTR-dependent anion secretion in pancreatic ductal epithelium.Cell Mol Biol Lett. 2024 Jan 23;29(1):18. doi: 10.1186/s11658-024-00537-1. Cell Mol Biol Lett. 2024. PMID: 38262945 Free PMC article.
-
A Gastroenterologist's Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care.Int J Mol Sci. 2023 Oct 30;24(21):15766. doi: 10.3390/ijms242115766. Int J Mol Sci. 2023. PMID: 37958749 Free PMC article. Review.
-
Efficacy and Safety of Elexacaftor-Tezacaftor-Ivacaftor in the Treatment of Cystic Fibrosis: A Systematic Review.Children (Basel). 2023 Mar 15;10(3):554. doi: 10.3390/children10030554. Children (Basel). 2023. PMID: 36980112 Free PMC article. Review.
-
Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France.Front Public Health. 2022 Nov 22;10:1043691. doi: 10.3389/fpubh.2022.1043691. eCollection 2022. Front Public Health. 2022. PMID: 36483264 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
